ARTV
Artiva Biotherapeutics, Inc. · Healthcare · Market cap $317.3M
Insiders bought $3.1M net in the last 90 days ·4 sellers, 1 buyer· 4 of 12 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 7, 2026
Insider Buying
$109.2M
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 7, 2026
Aslan Fred
Artiva Biotherapeutics, Inc. (ARTV) has 51 SEC Form 4 filings (69 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 7, 2026.
Inside the rolling window, 7 insiders at Artiva Biotherapeutics, Inc. reported 20 open-market purchases totaling $109.2M and 19 open-market sales totaling $2.5M. The most active filer is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. with 19 filings. Insiders have net bought $106.7M over the trailing 6 months. The largest single insider purchase in this window was $75.0M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on May 11, 2026. The most recent open-market filing is a sale of 23,463 shares by Chief Executive Officer Aslan Fred, dated Oct 6, 2026, worth $169K.
- Industry:Biotechnology
- CEO:Fred Aslan
- Employees:115
- HQ:San Diego, CA, US
- IPO:2024-07-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 23,463 | $169K | Oct 7 | -7.3% | SEC ↗ | |
| Chief Medical Officer | Sale | 1,099 | $8K | Oct 6 | -10.7% | SEC ↗ | |
| COO, CLO, Compliance Officer | Sale | 8,370 | $57K | Oct 6 | -10.7% | SEC ↗ | |
| Chief Tech Operations Officer | Sale | 10,340 | $71K | Oct 6 | -10.7% | SEC ↗ | |
| Chief Executive Officer | Sale | 61,696 | $422K | Oct 6 | -10.7% | SEC ↗ | |
| Chief Executive Officer | Sale | 23,429 | $256K | Sep 9 | -39.9% | SEC ↗ | |
Bush JenniferFirst in 4 months | COO, CLO, Compliance Officer | Sale | 8,391 | $94K | Sep 4 | -42.0% | SEC ↗ |
Aslan FredFirst in 4 months | Chief Executive Officer | Sale | 61,888 | $690K | Sep 4 | -42.0% | SEC ↗ |
Horan ChristopherFirst in 4 months | Chief Tech Operations Officer | Sale | 10,366 | $116K | Sep 4 | -42.0% | SEC ↗ |
| Chief Medical Officer | Sale | 1,100 | $12K | Sep 4 | -42.0% | SEC ↗ | |
| Chief Medical Officer | Sale | 8,222 | $99K | Aug 31 | — | SEC ↗ | |
Banerjee SubhashisFirst in 3 months | Chief Medical Officer | Sale | 429 | $5K | Aug 20 | — | SEC ↗ |
| Director, 10% Owner | Purchase | 20,824 | $208K | Jul 31 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 24,944 | $248K | Jul 31 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 41,319 | $413K | Jul 28 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 120,582 | $1.2M | Jul 24 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 84,124 | $835K | Jul 24 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 59,880 | $596K | Jul 24 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 13,074 | $117K | Jul 24 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 152,472 | $1.4M | Jul 20 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 7,882 | $71K | Jul 20 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 15,102 | $135K | Jul 14 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 31,000 | $275K | Jun 29 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 1,876 | $17K | Jun 29 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 391,019 | $3.4M | Jun 16 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ARTV have?
Artiva Biotherapeutics, Inc. (ARTV) has 51 SEC Form 4 filings (69 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 7, 2026.
When was the most recent SEC Form 4 filing for ARTV?
The most recent Form 4 filing for ARTV on Tracefour is dated Oct 7, 2026.
Who is the most active insider at ARTV?
The most active SEC Form 4 filer at ARTV in the rolling window is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P., with 19 filings.
What is the net insider flow at ARTV over the last 6 months?
Over the trailing 180 days, insiders at ARTV have net bought $106.7M based on SEC Form 4 disclosures.
What was the largest insider purchase at ARTV?
The largest single insider open-market purchase at ARTV in the rolling window was $75.0M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on 2026-05-11.
What is the total insider buy and sell value at ARTV in the current window?
Inside the rolling window, insiders at ARTV bought $109.2M and sold $2.5M based on SEC Form 4 filings.
Can I get alerts for ARTV insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Artiva Biotherapeutics, Inc. (ARTV). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Artiva Biotherapeutics, Inc. is in the Healthcare sector.